Your browser doesn't support javascript.
loading
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Aroor, Annayya R; Das, Nitin A; Carpenter, Andrea J; Habibi, Javad; Jia, Guanghong; Ramirez-Perez, Francisco I; Martinez-Lemus, Luis; Manrique-Acevedo, Camila M; Hayden, Melvin R; Duta, Cornel; Nistala, Ravi; Mayoux, Eric; Padilla, Jaume; Chandrasekar, Bysani; DeMarco, Vincent G.
Afiliación
  • Aroor AR; Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia, MO, USA.
  • Das NA; Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, USA.
  • Carpenter AJ; Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO, USA.
  • Habibi J; Cardiothoracic Surgery, University of Texas Health Science Center, San Antonio, San Antonio, TX, USA.
  • Jia G; Cardiothoracic Surgery, University of Texas Health Science Center, San Antonio, San Antonio, TX, USA.
  • Ramirez-Perez FI; Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia, MO, USA.
  • Martinez-Lemus L; Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, USA.
  • Manrique-Acevedo CM; Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO, USA.
  • Hayden MR; Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia, MO, USA.
  • Duta C; Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, USA.
  • Nistala R; Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO, USA.
  • Mayoux E; Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA.
  • Padilla J; Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA.
  • Chandrasekar B; Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, USA.
  • DeMarco VG; Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia, MO, USA.
Cardiovasc Diabetol ; 17(1): 108, 2018 07 30.
Article en En | MEDLINE | ID: mdl-30060748
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Circulación Renal / Compuestos de Bencidrilo / Glucemia / Diabetes Mellitus Tipo 2 / Angiopatías Diabéticas / Nefropatías Diabéticas / Transportador 2 de Sodio-Glucosa / Rigidez Vascular / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Circulación Renal / Compuestos de Bencidrilo / Glucemia / Diabetes Mellitus Tipo 2 / Angiopatías Diabéticas / Nefropatías Diabéticas / Transportador 2 de Sodio-Glucosa / Rigidez Vascular / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos